Skip to main content
Clinical Trials/NCT05544721
NCT05544721Enrolling By InvitationPhase 4

Pre-Operative and Post-Operative Paravertebral Block on Patients With Thoracic Outlet Syndrome.

Mayo Clinic1 site in 1 country50 target enrollmentStarted: October 5, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Enrolling By Invitation
Enrollment
50
Locations
1
Primary Endpoint
Change in pain level

Study Overview

Brief Summary

This research is being done to evaluate the effects of receiving only a paravertebral block prior to first rib resection procedure versus receiving the block both pre and post procedure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - All Thoracic Outlet Syndrome patients scheduled for first rib resection surgery.

Exclusion Criteria

  • Patients who are pregnant.
  • Patients with prior first rib resection on side of presentation.
  • Patients with complex regional pain syndrome (CRPS).
  • Patients with brachial plexus disorder.
  • Patients with cervical rib.

Arms & Interventions

Paravertebral block pre procedure

Active Comparator

Subjects will receive a preoperative paravertebral block only

Intervention: Ropivacaine (Drug)

Paravertebral block pre and post procedure

Active Comparator

Subjects will receive one paravertebral block, administered preoperatively and one paravertebral block, administered on postoperative day 1

Intervention: Ropivacaine (Drug)

Outcomes

Primary Outcomes

Change in pain level

Time Frame: Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op

Measured using the pain visual analog scale (VAS). The VAS line will be 100 mm long with each end marked with "no pain" on the left, and "worst possible pain" on the right; participant identify their pain level by indicating a point on the line between each end and this point is measured from the "No pain" end, and the number of millimeters is reported as the pain score.

Secondary Outcomes

  • Length of stay(Approximately 1 day)
  • Change in quality of life(Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Houssam Farres, M.D.

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials